tRNA synthetase: TRNA aminoacylation and beyond

Wiley Interdisciplinary Reviews: RNA

Volumn 5, Issue 4, 2014, Pages 461-480

  Pang, Yan Ling Joy ^a   Poruri, Kiranmai ^a   Martinis, Susan A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMINO ACID TRANSFER RNA LIGASE; GLYCINE TRANSFER RNA LIGASE; TRANSFER RNA;

AMINOACYLATION; ARTICLE; CLASSIFICATION; DRUG TARGETING; ENZYME BINDING; MACROMOLECULE; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; ANTAGONISTS AND INHIBITORS; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY;

AMINO ACYL-TRNA SYNTHETASES; HUMANS; MOLECULAR TARGETED THERAPY; RNA, TRANSFER; TRANSFER RNA AMINOACYLATION;

EID: 84902546406     PISSN: 17577004     EISSN: 17577012     Source Type: Journal    
DOI: 10.1002/wrna.1224     Document Type: Article

References (248)

1. Giegé R, Sissler M, Florentz C. Universal rules and idiosyncratic features in tRNA identity. Nucleic Acids Res 1998, 26:5017-5035.
2. Mascarenhas AP, An S, Rosen AE, Martinis SA, Musier-Forsyth K. Fidelity mechanisms of the aminoacyl-tRNA synthetases. In: RajBhandary UL, Köhrer C, eds. Protein Engineering. New York: Springer-Verlag; 2008, 155-193.
3. Guo M, Schimmel P, Yang XL. Functional expansion of human tRNA synthetases achieved by structural inventions. FEBS Lett 2010, 584:434-442.
4. Nawaz M, Martinis SA. Chemistry of aminoacyl-tRNA synthetases. In: Begley TP, eds. Encyclopedia of Chemical Biology. New York: John Wiley & Sons; 2009, 52-63.
5. Schimmel P, Ribas De Pouplana L. Footprints of aminoacyl-tRNA synthetases are everywhere. Trends Biochem Sci 2000, 25:207-209.
6. Guo M, Yang XL, Schimmel P. New functions of aminoacyl-tRNA synthetases beyond translation. Nat Rev Mol Cell Biol 2010, 11:668-674.
7. Cusack S, Berthet-Colominas C, Härtlein M, Nassar N, Leberman R. A second class of synthetase structure revealed by X-ray analysis of Escherichia coli seryl-tRNA synthetase at 2.5Å. Nature 1990, 347:249-255.
8. Eriani G, Delarue M, Poch O, Gangloff J, Moras D. Partition of tRNA synthetases into two classes based on mutually exclusive sets of sequence motifs. Nature 1990, 347:203-206.
9. Ribas de Pouplana L, Schimmel P. Two classes of tRNA synthetases suggested by sterically compatible dockings on tRNA acceptor stem. Cell 2001, 104:191-193.
10. Burbaum JJ, Schimmel P. Assembly of a class I tRNA synthetase from products of an artificially split gene. Biochemistry 1991, 30:319-324.
11. Cusack S. Eleven down and nine to go. Nat Struct Biol 1995, 2:824-831.
12. Landes C, Perona JJ, Brunie S, Rould MA, Zelwer C, Steitz TA, Risler JL. A structure-based multiple sequence alignment of all class I aminoacyl-tRNA synthetases. Biochimie 1995, 77:194-203.
13. Moras D. Structural and functional relationships between aminoacyl-tRNA synthetases. Trends Biochem Sci 1992, 17:159-164.
14. Ibba M, Morgan S, Curnow AW, Pridmore DR, Vothknecht UC, Gardner W, Lin W, Woese CR, Söll D. A euryarchaeal lysyl-tRNA synthetase: resemblance to class I synthetases. Science 1997, 278:1119-1122.
15. Irwin MJ, Nyborg J, Reid BR, Blow DM. The crystal structure of tyrosyl-transfer RNA synthetase at 2.7Å resolution. J Mol Biol 1976, 105:577-586.
16. Brick P, Bhat TN, Blow DM. Structure of tyrosyl-tRNA synthetase refined at 2.3Å resolution. Interaction of the enzyme with the tyrosyl adenylate intermediate. J Mol Biol 1989, 208:83-98.
17. Rould MA, Perona JJ, Soll D, Steitz TA. Structure of E. coli glutaminyl-tRNA synthetase complexed with tRNA(Gln) and ATP at 2.8 Å resolution. Science 1989, 246:1135-1142.
18. Schmitt E, Meinnel T, Blanquet S, Mechulam Y. Methionyl-tRNA synthetase needs an intact and mobile 332KMSKS336 motif in catalysis of methionyl adenylate formation. J Mol Biol 1994, 242:566-576.
19. Webster T, Tsai H, Kula M, Mackie GA, Schimmel P. Specific sequence homology and three-dimensional structure of an aminoacyl transfer RNA synthetase. Science 1984, 226:1315-1317.
20. Rock FL, Mao W, Yaremchuk A, Tukalo M, Crepin T, Zhou H, Zhang YK, Hernandez V, Akama T, Baker SJ, et al. An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site. Science 2007, 316:1759-1761.
21. Arnez JG, Dock-Bregeon AC, Moras D. Glycyl-tRNA synthetase uses a negatively charged pit for specific recognition and activation of glycine. J Mol Biol 1999, 286:1449-1459.
22. Perona JJ, Rould MA, Steitz TA. Structural basis for transfer RNA aminoacylation by Escherichia coli glutaminyl-tRNA synthetase. Biochemistry 1993, 32:8758-8771.
23. Arnez JG, Moras D. Structural and functional considerations of the aminoacylation reaction. Trends Biochem Sci 1997, 22:211-216.
24. Fersht AR, Knill-Jones JW, Bedouelle H, Winter G. Reconstruction by site-directed mutagenesis of the transition state for the activation of tyrosine by the tyrosyl-tRNA synthetase: a mobile loop envelopes the transition state in an induced-fit mechanism. Biochemistry 1988, 27:1581-1587.
25. First EA, Fersht AR. Analysis of the role of the KMSKS loop in the catalytic mechanism of the tyrosyl-tRNA synthetase using multimutant cycles. Biochemistry 1995, 34:5030-5043.
26. Ilyin VA, Temple B, Hu M, Li G, Yin Y, Vachette P, Carter CW Jr. 2.9Å crystal structure of ligand-free tryptophanyl-tRNA synthetase: domain movements fragment the adenine nucleotide binding site. Protein Sci 2000, 9:218-231.
27. Nakama T, Nureki O, Yokoyama S. Structural basis for the recognition of isoleucyl-adenylate and an antibiotic, mupirocin, by isoleucyl-tRNA synthetase. J Biol Chem 2001, 276:47387-47393.
28. Rossmann MG, Moras D, Olsen KW. Chemical and biological evolution of nucleotide-binding protein. Nature 1974, 250:194-199.
29. Arnez JG, Harris DC, Mitschler A, Rees B, Francklyn CS, Moras D. Crystal structure of histidyl-tRNA synthetase from Escherichia coli complexed with histidyl-adenylate. EMBO J 1995, 14:4143-4155.
30. Ruff M, Krishnaswamy S, Boeglin M, Poterszman A, Mitschler A, Podjarny A, Rees B, Thierry JC, Moras D. Class II aminoacyl transfer RNA synthetases: crystal structure of yeast aspartyl-tRNA synthetase complexed with tRNA(Asp). Science 1991, 252:1682-1689.
31. Cys formation. Proc Natl Acad Sci U S A 2005, 102:19003-19008.
32. Polycarpo C, Ambrogelly A, Berube A, Winbush SM, McCloskey JA, Crain PF, Wood JL, Söll D. An aminoacyl-tRNA synthetase that specifically activates pyrrolysine. Proc Natl Acad Sci U S A 2004, 101:12450-12454.
33. Polycarpo C, Ambrogelly A, Ruan B, Tumbula-Hansen D, Ataide SF, Ishitani R, Yokoyama S, Nureki O, Ibba M, Söll D. Activation of the pyrrolysine suppressor tRNA requires formation of a ternary complex with class I and class II lysyl-tRNA synthetases. Mol Cell 2003, 12:287-294.
34. Brick P, Blow DM. Crystal structure of a deletion mutant of a tyrosyl-tRNA synthetase complexed with tyrosine. J Mol Biol 1987, 194:287-297.
35. Belrhali H, Yaremchuk A, Tukalo M, Larsen K, Berthet-Colominas C, Leberman R, Beijer B, Sproat B, Als-Nielsen J, Grubel G, et al. Crystal structures at 2.5 Å resolution of seryl-tRNA synthetase complexed with two analogs of seryl adenylate. Science 1994, 263:1432-1436.
36. Sprinzl M, Cramer F. Site of aminoacylation of tRNAs from Escherichia coli with respect to the 2'- or 3'-hydroxyl group of the terminal adenosine. Proc Natl Acad Sci U S A 1975, 72:3049-3053.
37. Starzyk RM, Webster TA, Schimmel P. Evidence for dispensable sequences inserted into a nucleotide fold. Science 1987, 237:1614-1618.
38. Betha AK, Williams AM, Martinis SA. Isolated CP1 domain of Escherichia coli leucyl-tRNA synthetase is dependent on flanking hinge motifs for amino acid editing activity. Biochemistry 2007, 46:6258-6267.
39. Lin L, Hale SP, Schimmel P. Aminoacylation error correction. Nature 1996, 384:33-34.
40. Beuning PJ, Musier-Forsyth K. Hydrolytic editing by a class II aminoacyl-tRNA synthetase. Proc Natl Acad Sci U S A 2000, 97:8916-8920.
41. Wong FC, Beuning PJ, Nagan M, Shiba K, Musier-Forsyth K. Functional role of the prokaryotic proline-tRNA synthetase insertion domain in amino acid editing. Biochemistry 2002, 41:7108-7115.
42. Wong FC, Beuning PJ, Silvers C, Musier-Forsyth K. An isolated class II aminoacyl-tRNA synthetase insertion domain is functional in amino acid editing. J Biol Chem 2003, 278:52857-52864.
43. Ahel I, Korencic D, Ibba M, Söll D. Trans-editing of mischarged tRNAs. Proc Natl Acad Sci U S A 2003, 100:15422-15427.
44. Tyr. J Mol Biol 1993, 231:219-229.
45. Asahara H, Himeno H, Tamura K, Nameki N, Hasegawa T, Shimizu M. Discrimination among E. coli tRNAs with a long variable arm. Nucleic Acids Symp Ser 1993, 29:207-208.
46. Ser with seryl-tRNA synthetase studied by footprinting experiments. Eur J Biochem 1990, 188:283-290.
47. Normanly J, Ogden RC, Horvath SJ, Abelson J. Changing the identity of a transfer RNA. Nature 1986, 321:213-219.
48. Park SJ, Schimmel P. Evidence for interaction of an aminoacyl transfer RNA synthetase with a region important for the identity of its cognate transfer RNA. J Biol Chem 1988, 263:16527-16530.
49. Hsu JL, Martinis SA. A flexible peptide tether controls accessibility of a unique C-terminal RNA-binding domain in leucyl-tRNA synthetases. J Mol Biol 2008, 376:482-491.
50. Leu in the post-transfer-editing conformation. Nat Struct Mol Biol 2005, 12:923-930.
51. Nureki O, Vassylyev DG, Katayanagi K, Shimizu T, Sekine S, Kigawa T, Miyazawa T, Yokoyama S, Morikawa K. Architectures of class-defining and specific domains of glutamyl-tRNA synthetase. Science 1995, 267:1958-1965.
52. Shiba K, Suzuki N, Shigesada K, Namba Y, Schimmel P, Noda T. Human cytoplasmic isoleucyl-tRNA synthetase: selective divergence of the anticodon-binding domain and acquisition of a new structural unit. Proc Natl Acad Sci U S A 1994, 91:7435-7439.
53. Akins RA, Lambowitz AM. A protein required for splicing group I introns in Neurospora mitochondria is mitochondrial tyrosyl-tRNA synthetase or a derivative thereof. Cell 1987, 50:331-345.
54. Cherniack AD, Garriga G, Kittle JD Jr, Akins RA, Lambowitz AM. Function of Neurospora mitochondrial tyrosyl-tRNA synthetase in RNA splicing requires an idiosyncratic domain not found in other synthetases. Cell 1990, 62:745-755.
55. Mohr G, Rennard R, Cherniack AD, Stryker J, Lambowitz AM. Function of the Neurospora crassa mitochondrial tyrosyl-tRNA synthetase in RNA splicing. Role of the idiosyncratic N-terminal extension and different modes of interaction with different group I introns. J Mol Biol 2001, 307:75-92.
56. Paukstelis PJ, Coon R, Madabusi L, Nowakowski J, Monzingo A, Robertus J, Lambowitz AM. A tyrosyl-tRNA synthetase adapted to function in group I intron splicing by acquiring a new RNA binding surface. Mol Cell 2005, 17:417-428.
57. Paukstelis PJ, Chen JH, Chase E, Lambowitz AM, Golden BL. Structure of a tyrosyl-tRNA synthetase splicing factor bound to a group I intron RNA. Nature 2008, 451:94-97.
58. Wakasugi K, Schimmel P. Highly differentiated motifs responsible for two cytokine activities of a split human tRNA synthetase. J Biol Chem 1999, 274:23155-23159.
59. Wakasugi K, Schimmel P. Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science 1999, 284:147-151.
60. Kleeman TA, Wei D, Simpson KL, First EA. Human tyrosyl-tRNA synthetase shares amino acid sequence homology with a putative cytokine. J Biol Chem 1997, 272:14420-14425.
61. Kao J, Houck K, Fan Y, Haehnel I, Libutti SK, Kayton ML, Grikscheit T, Chabot J, Nowygrod R, Greenberg S, et al. Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II. J Biol Chem 1994, 269:25106-25119.
62. Kao J, Ryan J, Brett G, Chen J, Shen H, Fan YG, Godman G, Familletti PC, Wang F, Pan Y-C, et al. Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. J Biol Chem 1992, 267:20239-20247.
63. Bec G, Kerjan P, Waller JP. Reconstitution in vitro of the valyl-tRNA synthetase-elongation factor (EF) 1 β γ δ complex. Essential roles of the NH2-terminal extension of valyl-tRNA synthetase and of the EF-1 δ subunit in complex formation. J Biol Chem 1994, 269:2086-2092.
64. Jiang S, Wolfe CL, Warrington JA, Norcum MT. Three-dimensional reconstruction of the valyl-tRNA synthetase/elongation factor-1H complex and localization of the δ subunit. FEBS Lett 2005, 579:6049-6054.
65. Kim JE, Kim KH, Lee SW, Seol W, Shiba K, Kim S. An elongation factor-associating domain is inserted into human cysteinyl-tRNA synthetase by alternative splicing. Nucleic Acids Res 2000, 28:2866-2872.
66. Kim KJ, Park MC, Choi SJ, Oh YS, Choi EC, Cho HJ, Kim MH, Kim SH, Kim DW, Kim S, et al. Determination of three-dimensional structure and residues of the novel tumor suppressor AIMP3/p18 required for the interaction with ATM. J Biol Chem 2008, 283:14032-14040.
67. Negrutskii BS, Shalak VF, Kerjan P, El'skaya AV, Mirande M. Functional interaction of mammalian valyl-tRNA synthetase with elongation factor EF-1α in the complex with EF-1H. J Biol Chem 1999, 274:4545-4550.
68. Quevillon S, Robinson JC, Berthonneau E, Siatecka M, Mirande M. Macromolecular assemblage of aminoacyl-tRNA synthetases: identification of protein-protein interactions and characterization of a core protein. J Mol Biol 1999, 285:183-195.
69. Simader H, Hothorn M, Kohler C, Basquin J, Simos G, Suck D. Structural basis of yeast aminoacyl-tRNA synthetase complex formation revealed by crystal structures of two binary sub-complexes. Nucleic Acids Res 2006, 34:3968-3979.
70. Cahuzac B, Berthonneau E, Birlirakis N, Guittet E, Mirande M. A recurrent RNA-binding domain is appended to eukaryotic aminoacyl-tRNA synthetases. EMBO J 2000, 19:445-452.
71. Cerini C, Semeriva M, Gratecos D. Evolution of the aminoacyl-tRNA synthetase family and the organization of the Drosophila glutamyl-prolyl-tRNA synthetase gene. Intron/exon structure of the gene, control of expression of the two mRNAs, selective advantage of the multienzyme complex. Eur J Biochem 1997, 244:176-185.
72. Ewalt KL, Yang XL, Otero FJ, Liu J, Slike B, Schimmel P. Variant of human enzyme sequesters reactive intermediate. Biochemistry 2005, 44:4216-4221.
73. Jia J, Arif A, Ray PS, Fox PL. WHEP domains direct noncanonical function of glutamyl-prolyl tRNA synthetase in translational control of gene expression. Mol Cell 2008, 29:679-690.
74. Kerjan P, Triconnet M, Waller JP. Mammalian prolyl-tRNA synthetase corresponds to the approximately 150kDa subunit of the high-M(r) aminoacyl-tRNA synthetase complex. Biochimie 1992, 74:195-205.
75. Mukhopadhyay R, Jia J, Arif A, Ray PS, Fox PL. The GAIT system: a gatekeeper of inflammatory gene expression. Trends Biochem Sci 2009, 34:324-331.
76. Rho SB, Lee JS, Jeong EJ, Kim KS, Kim YG, Kim S. A multifunctional repeated motif is present in human bifunctional tRNA synthetase. J Biol Chem 1998, 273:11267-11273.
77. Yang XL, Otero FJ, Skene RJ, McRee DE, Schimmel P, Ribas de Pouplana L. Crystal structures that suggest late development of genetic code components for differentiating aromatic side chains. Proc Natl Acad Sci U S A 2003, 100:15376-15380.
78. Kaminska M, Deniziak M, Kerjan P, Barciszewski J, Mirande M. A recurrent general RNA binding domain appended to plant methionyl-tRNA synthetase acts as a cis-acting cofactor for aminoacylation. EMBO J 2000, 19:6908-6917.
79. Kim Y, Shin J, Li R, Cheong C, Kim K, Kim S. A novel anti-tumor cytokine contains an RNA binding motif present in aminoacyl-tRNA synthetases. J Biol Chem 2000, 275:27062-27068.
80. Quevillon S, Agou F, Robinson JC, Mirande M. The p43 component of the mammalian multi-synthetase complex is likely to be the precursor of the endothelial monocyte-activating polypeptide II cytokine. J Biol Chem 1997, 272:32573-32579.
81. Renault L, Kerjan P, Pasqualato S, Menetrey J, Robinson JC, Kawaguchi S, Vassylyev DG, Yokoyama S, Mirande M, Cherfils J. Structure of the EMAPII domain of human aminoacyl-tRNA synthetase complex reveals evolutionary dimer mimicry. EMBO J 2001, 20:570-578.
82. Robinson JC, Kerjan P, Mirande M. Macromolecular assemblage of aminoacyl-tRNA synthetases: quantitative analysis of protein-protein interactions and mechanism of complex assembly. J Mol Biol 2000, 304:983-994.
83. Rose A, Schraegle SJ, Stahlberg EA, Meier I. Coiled-coil protein composition of 22 proteomes-differences and common themes in subcellular infrastructure and traffic control. BMC Evol Biol 2005, 5:66.
84. Vellekamp G, Sihag RK, Deutscher MP. Comparison of the complexed and free forms of rat liver arginyl-tRNA synthetase and origin of the free form. J Biol Chem 1985, 260:9843-9847.
85. Zheng YG, Wei H, Ling C, Xu MG, Wang ED. Two forms of human cytoplasmic arginyl-tRNA synthetase produced from two translation initiations by a single mRNA. Biochemistry 2006, 45:1338-1344.
86. Woese CR. On the evolution of the genetic code. Proc Natl Acad Sci U S A 1965, 54:1546-1552.
87. Woese CR. On the evolution of cells. Proc Natl Acad Sci U S A 2002, 99:8742-8747.
88. Karkhanis VA, Boniecki MT, Poruri K, Martinis SA. A viable amino acid editing activity in the leucyl-tRNA synthetase CP1-splicing domain is not required in the yeast mitochondria. J Biol Chem 2006, 281:33217-33225.
89. Karkhanis VA, Mascarenhas AP, Martinis SA. Amino acid toxicities of Escherichia coli that are prevented by leucyl-tRNA synthetase amino acid editing. J Bacteriol 2007, 189:8765-8768.
90. Lee JW, Beebe K, Nangle LA, Jang J, Longo-Guess CM, Cook SA, Davisson MT, Sundberg JP, Schimmel P, Ackerman SL. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature 2006, 443:50-55.
91. Nangle LA, Motta CM, Schimmel P. Global effects of mistranslation from an editing defect in mammalian cells. Chem Biol 2006, 13:1091-1100.
92. Geslain R, Ribas de Pouplana L. Regulation of RNA function by aminoacylation and editing? Trends Genet 2004, 20:604-610.
93. Hendrickson TL, Schimmel P. Transfer RNA-dependent amino acid discrimination by aminoacyl-tRNA synthetases. In: Lapointe J, Brakier-Gingras L, eds. Translation Mechanisms. Georgetown, TX: Landes Bioscience; 2002, 34-64.
94. Pauling L. The probability of errors in the process of synthesis of protein molecules. In: Birkhauser A, eds. Festschrift Authur Stöll Siebzigsten Geburtstag. Basel: Birkhauser Verlag; 1958, 597-602.
95. Loftfield RB. The frequency of errors in protein biosynthesis. Biochem J 1963, 89:82-92.
96. Baldwin AN, Berg P. Transfer ribonucleic acid-induced hydrolysis of valyladenylate bound to isoleucyl ribonucleic acid synthetase. J Biol Chem 1966, 241:839-845.
97. Fersht AR. Editing mechanisms in protein synthesis. Rejection of valine by the isoleucyl-tRNA synthetase. Biochemistry 1977, 16:1025-1030.
98. Mursinna RS, Martinis SA. Rational design to block amino acid editing of a tRNA synthetase. J Am Chem Soc 2002, 124:7286-7287.
99. Lin L, Schimmel P. Mutational analysis suggests the same design for editing activities of two tRNA synthetases. Biochemistry 1996, 35:5596-5601.
100. Schmidt E, Schimmel P. Mutational isolation of a sieve for editing in a transfer RNA synthetase. Science 1994, 264:265-267.
101. Schmidt E, Schimmel P. Residues in a class I tRNA synthetase which determine selectivity of amino acid recognition in the context of tRNA. Biochemistry 1995, 34:11204-11210.
102. Nureki O, Vassylyev DG, Tateno M, Shimada A, Nakama T, Fukai S, Konno M, Hendrickson TL, Schimmel P, Yokoyama S. Enzyme structure with two catalytic sites for double-sieve selection of substrate. Science 1998, 280:578-582.
103. Dock-Bregeon A, Sankaranarayanan R, Romby P, Caillet J, Springer M, Rees B, Francklyn CS, Ehresmann C, Moras D. Transfer RNA-mediated editing in threonyl-tRNA synthetase. The class II solution to the double discrimination problem. Cell 2000, 103:877-884.
104. Sankaranarayanan R, Dock-Bregeon AC, Rees B, Bovee M, Caillet J, Romby P, Francklyn CS, Moras D. Zinc ion mediated amino acid discrimination by threonyl-tRNA synthetase. Nat Struct Biol 2000, 7:461-465.
105. Pro by Haemophilus influenzae YbaK protein. J Biol Chem 2004, 279:42359-42362.
106. Chong YE, Yang XL, Schimmel P. Natural homolog of tRNA synthetase editing domain rescues conditional lethality caused by mistranslation. J Biol Chem 2008, 283:30073-30078.
107. Hellmann RA, Martinis SA. Defects in transient tRNA translocation bypass tRNA synthetase quality control mechanisms. J Biol Chem 2009, 284:11478-11484.
108. Palencia A, Crepin T, Vu MT, Lincecum TL Jr, Martinis SA, Cusack S. Structural dynamics of the aminoacylation and proofreading functional cycle of bacterial leucyl-tRNA synthetase. Nat Struct Mol Biol 2012, 19:677-684.
109. Mascarenhas AP, Martinis SA. Functional segregation of a predicted "hinge" site within the β-strand linkers of Escherichia coli leucyl-tRNA synthetase. Biochemistry 2008, 47:4808-4816.
110. Mascarenhas AP, Martinis SA. A glycine hinge for tRNA-dependent translocation of editing substrates to prevent errors by leucyl-tRNA synthetase. FEBS Lett 2009, 583:3443-3447.
111. Bishop AC, Nomanbhoy TK, Schimmel P. Blocking site-to-site translocation of a misactivated amino acid by mutation of a class I tRNA synthetase. Proc Natl Acad Sci U S A 2002, 99:585-590.
112. Eldred EW, Schimmel PR. Rapid deacylation by isoleucyl transfer ribonucleic acid synthetase of isoleucine-specific transfer ribonucleic acid aminoacylated with valine. J Biol Chem 1972, 247:2961-2964.
113. Jakubowski H. Aminoacyl thioester chemistry of class II aminoacyl-tRNA synthetases. Biochemistry 1997, 36:11077-11085.
114. Boniecki MT, Vu MT, Betha AK, Martinis SA. CP1-dependent partitioning of pretransfer and posttransfer editing in leucyl-tRNA synthetase. Proc Natl Acad Sci U S A 2008, 105:19223-19228.
115. Dulic M, Cvetesic N, Perona JJ, Gruic-Sovulj I. Partitioning of tRNA-dependent editing between pre- and post-transfer pathways in class I aminoacyl-tRNA synthetases. J Biol Chem 2010, 285:23799-23809.
116. Gruic-Sovulj I, Uter N, Bullock T, Perona JJ. tRNA-dependent aminoacyl-adenylate hydrolysis by a nonediting class I aminoacyl-tRNA synthetase. J Biol Chem 2005, 280:23978-23986.
117. Minajigi A, Francklyn CS. Aminoacyl transfer rate dictates choice of editing pathway in threonyl-tRNA synthetase. J Biol Chem 2010, 285:23810-23817.
118. Lincecum TL Jr, Tukalo M, Yaremchuk A, Mursinna RS, Williams AM, Sproat BS, Van Den Eynde W, Link A, Van Calenbergh S, Grøtli M, et al. Structural and mechanistic basis of pre- and post-transfer editing by leucyl-tRNA synthetase. Mol Cell 2003, 11:951-963.
119. Li L, Boniecki MT, Jaffe JD, Imai BS, Yau PM, Luthey-Schulten ZA, Martinis SA. Naturally occurring aminoacyl-tRNA synthetases editing-domain mutations that cause mistranslation in Mycoplasma parasites. Proc Natl Acad Sci U S A 2011, 108:9378-9383.
120. Li L, Palencia A, Lukk T, Li Z, Luthey-Schulten ZA, Cusack S, Martinis SA, Boniecki MT. Leucyl-tRNA synthetase editing domain functions as a molecular rheostat to control codon ambiguity in Mycoplasma pathogens. Proc Natl Acad Sci U S A 2013, 110:3817-3822.
121. Englisch S, Englisch U, von der Haar F, Cramer F. The proofreading of hydroxy analogues of leucine and isoleucine by leucyl-tRNA synthetases from E. coli and yeast. Nucleic Acids Res 1986, 14:7529-7539.
122. Fersht AR, Dingwall C. Evidence for the double-sieve editing mechanism in protein synthesis. Steric exclusion of isoleucine by valyl-tRNA synthetases. Biochemistry 1979, 18:2627-2631.
123. Martinis SA, Boniecki MT. The balance between pre- and post-transfer editing in tRNA synthetases. FEBS Lett 2010, 584:455-459.
124. Williams AM, Martinis SA. Mutational unmasking of a tRNA-dependent pathway for preventing genetic code ambiguity. Proc Natl Acad Sci U S A 2006, 103:3586-3591.
125. Splan KE, Musier-Forsyth K, Boniecki MT, Martinis SA. In vitro assays for the determination of aminoacyl-tRNA synthetase editing activity. Methods 2008, 44:119-128.
126. Chen X, Ma JJ, Tan M, Yao P, Hu QH, Eriani G, Wang ED. Modular pathways for editing non-cognate amino acids by human cytoplasmic leucyl-tRNA synthetase. Nucleic Acids Res 2011, 39:235-247.
127. Sarkar J, Martinis SA. Amino-acid-dependent shift in tRNA synthetase editing mechanisms. J Am Chem Soc 2011, 133:18510-18513.
128. Pang YL, Martinis SA. A paradigm shift for the amino acid editing mechanism of human cytoplasmic leucyl-tRNA synthetase. Biochemistry 2009, 48:8958-8964.
129. Santos MAS, Tuite MF. The CUG codon is decoded in vivo as serine and not leucine in Candida albicans. Nucleic Acids Res 1995, 23:1481-1486.
130. Gomes AC, Miranda I, Silva RM, Moura GR, Thomas B, Akoulitchev A, Santos MA. A genetic code alteration generates a proteome of high diversity in the human pathogen Candida albicans. Genome Biol 2007, 8:R206.
131. Phe and general structural features of other tRNAs. In: Schimmel P, Söll D, Abelson JM, eds. Transfer RNA: Structure, Properties, and Recognition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1979, 83-100.
132. Hou YM, Schimmel P. A simple structural feature is a major determinant of the identity of a transfer RNA. Nature 1988, 333:140-145.
133. McClain WH, Foss K. Changing the identity of a tRNA by introducing a G-U wobble pair near the 3' acceptor end. Science 1988, 240:793-796.
134. Normanly J, Ollick T, Abelson J. Eight base changes are sufficient to convert a leucine-inserting tRNA into a serine-inserting tRNA. Proc Natl Acad Sci U S A 1992, 89:5680-5684.
135. Leu aminoacylation and amino acid editing using minimalist RNA molecules. Nucleic Acids Res 2002, 30:2103-2113.
136. Crothers DM, Seno T, Söll G. Is there a discriminator site in transfer RNA? Proc Natl Acad Sci U S A 1972, 69:3063-3067.
137. McClain WH, Chen YM, Foss K, Schneider J. Association of transfer RNA acceptor identity with a helical irregularity. Science 1988, 242:1681-1684.
138. Ser: sequence elements necessary for serylation and maturation of a tRNA with a long extra arm. EMBO J 1993, 12:3333-3338.
139. Muramatsu T, Nishikawa K, Nemoto F, Kuchino Y, Nishimura S, Miyazawa T, Yokoyama S. Codon and amino-acid specificities of a transfer RNA are both converted by a single post-transcriptional modification. Nature 1988, 336:179-181.
140. Perret V, Garcia A, Grosjean H, Ebel JP, Florentz C, Giegé R. Relaxation of a transfer RNA specificity by removal of modified nucleotides. Nature 1990, 344:787-789.
141. Putz J, Florentz C, Benseler F, Giegé R. A single methyl group prevents the mischarging of a tRNA. Nat Struct Biol 1994, 1:580-582.
142. Ser into a leucine acceptor in vitro. Nucleic Acids Res 1995, 23:3633-3637.
143. Leu. J Mol Biol 1996, 263:707-714.
144. Sethi A, Eargle J, Black AA, Luthey-Schulten Z. Dynamical networks in tRNA:protein complexes. Proc Natl Acad Sci U S A 2009, 106:6620-6625.
145. Lee SW, Cho BH, Park SG, Kim S. Aminoacyl-tRNA synthetase complexes: beyond translation. J Cell Sci 2004, 117(Pt 17):3725-3734.
146. Deutscher MP. The eucaryotic aminoacyl-tRNA synthetase complex: suggestions for its structure and function. J Cell Biol 1984, 99:373-377.
147. Ray PS, Arif A, Fox PL. Macromolecular complexes as depots for releasable regulatory proteins. Trends Biochem Sci 2007, 32:158-164.
148. Berthonneau E, Mirande M. A gene fusion event in the evolution of aminoacyl-tRNA synthetases. FEBS Lett 2000, 470:300-304.
149. Jeong EJ, Hwang GS, Kim KH, Kim MJ, Kim S, Kim KS. Structural analysis of multifunctional peptide motifs in human bifunctional tRNA synthetase: identification of RNA-binding residues and functional implications for tandem repeats. Biochemistry 2000, 39:15775-15782.
150. Kaminska M, Havrylenko S, Decottignies P, Gillet S, Le Marechal P, Negrutskii B, Mirande M. Dissection of the structural organization of the aminoacyl-tRNA synthetase complex. J Biol Chem 2009, 284:6053-6060.
151. Park SG, Ewalt KL, Kim S. Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on housekeepers. Trends Biochem Sci 2005, 30:569-574.
152. Norcum MT, Boisset N. Three-dimensional architecture of the eukaryotic multisynthetase complex determined from negatively stained and cryoelectron micrographs. FEBS Lett 2002, 512(1-3):298-302.
153. Norcum MT, Warrington JA. Structural analysis of the multienzyme aminoacyl-tRNA synthetase complex: a three-domain model based on reversible chemical crosslinking. Protein Sci 1998, 7:79-87.
154. Ahn HC, Kim S, Lee BJ. Solution structure and p43 binding of the p38 leucine zipper motif: coiled-coil interactions mediate the association between p38 and p43. FEBS Lett 2003, 542(1-3):119-124.
155. Norcum MT, Warrington JA. The cytokine portion of p43 occupies a central position within the eukaryotic multisynthetase complex. J Biol Chem 2000, 275:17921-17924.
156. Park SG, Jung KH, Lee JS, Jo YJ, Motegi H, Kim S, Shiba K. Precursor of pro-apoptotic cytokine modulates aminoacylation activity of tRNA synthetase. J Biol Chem 1999, 274:16673-16676.
157. Yannay-Cohen N, Carmi-Levy I, Kay G, Yang CM, Han JM, Kemeny DM, Kim S, Nechushtan H, Razin E. LysRS serves as a key signaling molecule in the immune response by regulating gene expression. Mol Cell 2009, 34:603-611.
158. Han JM, Park BJ, Park SG, Oh YS, Choi SJ, Lee SW, Hwang SK, Chang SH, Cho MH, Kim S. AIMP2/p38, the scaffold for the multi-tRNA synthetase complex, responds to genotoxic stresses via p53. Proc Natl Acad Sci U S A 2008, 105:11206-11211.
159. Han JM, Kwon NH, Lee JY, Jeong SJ, Jung HJ, Kim HR, Li Z, Kim S. Identification of gp96 as a novel target for treatment of autoimmune disease in mice. PLoS One 2010, 5:e9792.
160. Kim G, Han JM, Kim S. Toll-like receptor 4-mediated c-Jun N-terminal kinase activation induces gp96 cell surface expression via AIMP1 phosphorylation. Biochem Biophys Res Commun 2010, 397:100-105.
161. Lee YN, Nechushtan H, Figov N, Razin E. The function of lysyl-tRNA synthetase and Ap4A as signaling regulators of MITF activity in FcεRI-activated mast cells. Immunity 2004, 20:145-151.
162. Park SG, Kim HJ, Min YH, Choi EC, Shin YK, Park BJ, Lee SW, Kim S. Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response. Proc Natl Acad Sci U S A 2005, 102:6356-6361.
163. Nechushtan H, Kim S, Kay G, Razin E. The physiological role of lysyl tRNA synthetase in the immune system. Adv Immunol 2009, 103:1-27.
164. Mazumder B, Sampath P, Seshadri V, Maitra RK, DiCorleto PE, Fox PL. Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control. Cell 2003, 115:187-198.
165. Sampath P, Mazumder B, Seshadri V, Gerber CA, Chavatte L, Kinter M, Ting SM, Dignam JD, Kim S, Driscoll DM, et al. Noncanonical function of glutamyl-prolyl-tRNA synthetase: gene-specific silencing of translation. Cell 2004, 119:195-208.
166. Simos G, Segref A, Fasiolo F, Hellmuth K, Shevchenko A, Mann M, Hurt EC. The yeast protein Arc1p binds to tRNA and functions as a cofactor for the methionyl- and glutamyl-tRNA synthetases. EMBO J 1996, 15:5437-5448.
167. Frechin M, Senger B, Brayé M, Kern D, Martin RP, Becker HD. Yeast mitochondrial Gln-tRNA(Gln) is generated by a GatFAB-mediated transamidation pathway involving Arc1p-controlled subcellular sorting of cytosolic GluRS. Genes Dev 2009, 23:1119-1130.
168. Praetorius-Ibba M, Hausmann CD, Paras M, Rogers TE, Ibba M. Functional association between three archaeal aminoacyl-tRNA synthetases. J Biol Chem 2007, 282:3680-3687.
169. Pro aminoacylation. J Biol Chem 2005, 280:26099-26104.
170. Hausmann CD, Praetorius-Ibba M, Ibba M. An aminoacyl-tRNA synthetase:elongation factor complex for substrate channeling in archaeal translation. Nucleic Acids Res 2007, 35:6094-6102.
171. Park SG, Shin H, Shin YK, Lee Y, Choi EC, Park BJ, Kim S. The novel cytokine p43 stimulates dermal fibroblast proliferation and wound repair. Am J Pathol 2005, 166:387-398.
172. Han JM, Park SG, Lee Y, Kim S. Structural separation of different extracellular activities in aminoacyl-tRNA synthetase-interacting multi-functional protein, p43/AIMP1. Biochem Biophys Res Commun 2006, 342:113-118.
173. Park SG, Kang YS, Ahn YH, Lee SH, Kim KR, Kim KW, Koh GY, Ko YG, Kim S. Dose-dependent biphasic activity of tRNA synthetase-associating factor, p43, in angiogenesis. J Biol Chem 2002, 277:45243-45248.
174. Han JM, Park SG, Liu B, Park BJ, Kim JY, Jin CH, Song YW, Li Z, Kim S. Aminoacyl-tRNA synthetase-interacting multifunctional protein 1/p43 controls endoplasmic reticulum retention of heat shock protein gp96: its pathological implications in lupus-like autoimmune diseases. Am J Pathol 2007, 170:2042-2054.
175. Ko HS, von Coelln R, Sriram SR, Kim SW, Chung KK, Pletnikova O, Troncoso J, Johnson B, Saffary R, Goh EL, et al. Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death. J Neurosci 2005, 25:7968-7978.
176. Park BJ, Kang JW, Lee SW, Choi SJ, Shin YK, Ahn YH, Choi YH, Choi D, Lee KS, Kim S. The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR. Cell 2005, 120:209-221.
177. Martinis SA, Plateau P, Cavarelli J, Florentz C. Aminoacyl-tRNA synthetases: a family of expanding functions. EMBO J 1999, 18:4591-4596.
178. Martinis SA, Joy Pang YL. Jekyll & Hyde: evolution of a superfamily. Chem Biol 2007, 14:1307-1308.
179. Park SG, Schimmel P, Kim S. Aminoacyl tRNA synthetases and their connections to disease. Proc Natl Acad Sci U S A 2008, 105:11043-11049.
180. Herbert CJ, Labouesse M, Dujardin G, Slonimski PP. The NAM2 proteins from S. cerevisiae and S. douglasii are mitochondrial leucyl-tRNA synthetases, and are involved in mRNA splicing. EMBO J 1988, 7:473-483.
181. Kämper U, Kuck U, Cherniack AD, Lambowitz AM. The mitochondrial tyrosyl-tRNA synthetase of Podospora anserina is a bifunctional enzyme active in protein synthesis and RNA splicing. Mol Cell Biol 1992, 12:499-511.
182. Labouesse M. The yeast mitochondrial leucyl-tRNA synthetase is a splicing factor for the excision of several group I introns. Mol Gen Genet 1990, 224:209-221.
183. Labouesse M, Dujardin G, Slonimski PP. The yeast nuclear gene NAM2 is essential for mitochondrial DNA integrity and can cure a mitochondrial RNA-maturase deficiency. Cell 1985, 41:133-143.
184. Romby P, Caillet J, Ebel C, Sacerdot C, Graffe M, Eyermann F, Brunel C, Moine H, Ehresmann C, Ehresmann B, et al. The expression of E. coli threonyl-tRNA synthetase is regulated at the translational level by symmetrical operator-repressor interactions. EMBO J 1996, 15:5976-5987.
185. Condon C, Grunberg-Manago M, Putzer H. Aminoacyl-tRNA synthetase gene regulation in Bacillus subtilis. Biochimie 1996, 78:381-389.
186. Putney SD, Schimmel P. An aminoacyl tRNA synthetase binds to a specific DNA sequence and regulates its gene transcription. Nature 1981, 291:632-635.
187. Antonellis A, Ellsworth RE, Sambuughin N, Puls I, Abel A, Lee-Lin SQ, Jordanova A, Kremensky I, Christodoulou K, Middleton LT, et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 2003, 72:1293-1299.
188. Jordanova A, Irobi J, Thomas FP, Van Dijck P, Meerschaert K, Dewil M, Dierick I, Jacobs A, De Vriendt E, Guergueltcheva V, et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 2006, 38:197-202.
189. Storkebaum E, Leitao-Goncalves R, Godenschwege T, Nangle L, Mejia M, Bosmans I, Ooms T, Jacobs A, Van Dijck P, Yang XL, et al. Dominant mutations in the tyrosyl-tRNA synthetase gene recapitulate in Drosophila features of human Charcot-Marie-Tooth neuropathy. Proc Natl Acad Sci U S A 2009, 106:11782-11787.
190. Nangle LA, Zhang W, Xie W, Yang XL, Schimmel P. Charcot-Marie-Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect. Proc Natl Acad Sci U S A 2007, 104:11239-11244.
191. Mathews MB, Bernstein RM. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 1983, 304:177-179.
192. Raben N, Nichols R, Dohlman J, McPhie P, Sridhar V, Hyde C, Leff R, Plotz P. A motif in human histidyl-tRNA synthetase which is shared among several aminoacyl-tRNA synthetases is a coiled-coil that is essential for enzymatic activity and contains the major autoantigenic epitope. J Biol Chem 1994, 269:24277-24283.
193. Beaulande M, Tarbouriech N, Hartlein M. Human cytosolic asparaginyl-tRNA synthetase: cDNA sequence, functional expression in Escherichia coli and characterization as human autoantigen. Nucleic Acids Res 1998, 26:521-524.
194. Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP, Mimori T, Akizuki M, Targoff IN. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol 1999, 162:2315-2320.
195. Hirakata M, Suwa A, Takeda Y, Matsuoka Y, Irimajiri S, Targoff IN, Hardin JA, Craft J. Autoantibodies to glycyl-transfer RNA synthetase in myositis. Association with dermatomyositis and immunologic heterogeneity. Arthritis Rheum 1996, 39:146-151.
196. Targoff IN. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J Immunol 1990, 144:1737-1743.
197. Targoff IN, Trieu EP, Miller FW. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. J Clin Invest 1993, 91:2556-2564.
198. Castro de Moura M, Miro F, Han JM, Kim S, Celada A, Ribas de Pouplana L. Entamoeba lysyl-tRNA synthetase contains a cytokine-like domain with chemokine activity towards human endothelial cells. PLoS Negl Trop Dis 2011, 5:e1398.
199. Sajish M, Zhou Q, Kishi S, Valdez DM Jr, Kapoor M, Guo M, Lee S, Kim S, Yang XL, Schimmel P. Trp-tRNA synthetase bridges DNA-PKcs to PARP-1 to link IFN-γ and p53 signaling. Nat Chem Biol 2012, 8:547-554.
200. Park MC, Kang T, Jin D, Han JM, Kim SB, Park YJ, Cho K, Park YW, Guo M, He W, et al. Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis. Proc Natl Acad Sci U S A 2012, 109:E640-E647.
201. Howard OM, Dong HF, Yang D, Raben N, Nagaraju K, Rosen A, Casciola-Rosen L, Hartlein M, Kron M, Yang D, et al. Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med 2002, 196:781-791.
202. Kepp O, Gdoura A, Martins I, Panaretakis T, Schlemmer F, Tesniere A, Fimia GM, Ciccosanti F, Burgevin A, Piacentini M, et al. Lysyl tRNA synthetase is required for the translocation of calreticulin to the cell surface in immunogenic death. Cell Cycle 2010, 9:3072-3077.
203. Arif A, Jia J, Moodt RA, DiCorleto PE, Fox PL. Phosphorylation of glutamyl-prolyl tRNA synthetase by cyclin-dependent kinase 5 dictates transcript-selective translational control. Proc Natl Acad Sci U S A 2011, 108:1415-1420.
204. Yao P, Potdar AA, Arif A, Ray PS, Mukhopadhyay R, Willard B, Xu Y, Yan J, Saidel GM, Fox PL. Coding region polyadenylation generates a truncated tRNA synthetase that counters translation repression. Cell 2012, 149:88-100.
205. Park SJ, Kim SH, Choi HS, Rhee Y, Lim SK. Fibroblast growth factor 2-induced cytoplasmic asparaginyl-tRNA synthetase promotes survival of osteoblasts by regulating anti-apoptotic PI3K/Akt signaling. Bone 2009, 45:994-1003.
206. Ramirez BL, Howard OM, Dong HF, Edamatsu T, Gao P, Härtlein M, Kron M. Brugia malayi asparaginyl-transfer RNA synthetase induces chemotaxis of human leukocytes and activates G-protein-coupled receptors CXCR1 and CXCR2. J Infect Dis 2006, 193:1164-1171.
207. Houman F, Rho SB, Zhang J, Shen X, Wang CC, Schimmel P, Martinis SA. A prokaryote and human tRNA synthetase provide an essential RNA splicing function in yeast mitochondria. Proc Natl Acad Sci U S A 2000, 97:13743-13748.
208. Rho SB, Lincecum TL Jr, Martinis SA. An inserted region of leucyl-tRNA synthetase plays a critical role in group I intron splicing. EMBO J 2002, 21:6874-6881.
209. Boniecki MT, Rho SB, Tukalo M, Hsu JL, Romero EP, Martinis SA. Leucyl-tRNA synthetase-dependent and -independent activation of a group I intron. J Biol Chem 2009, 284:26243-26250.
210. Caprara MG, Mohr G, Lambowitz AM. A tyrosyl-tRNA synthetase protein induces tertiary folding of the group I intron catalytic core. J Mol Biol 1996, 257:512-531.
211. Cen S, Khorchid A, Javanbakht H, Gabor J, Stello T, Shiba K, Musier-Forsyth K, Kleiman L. Incorporation of lysyl-tRNA synthetase into human immunodeficiency virus type 1. J Virol 2001, 75:5043-5048.
212. Lys packaging complex in HIV-1. FEBS Lett 2010, 584:359-365.
213. Halwani R, Cen S, Javanbakht H, Saadatmand J, Kim S, Shiba K, Kleiman L. Cellular distribution of lysyl-tRNA synthetase and its interaction with Gag during human immunodeficiency virus type 1 assembly. J Virol 2004, 78:7553-7564.
214. Javanbakht H, Halwani R, Cen S, Saadatmand J, Musier-Forsyth K, Gottlinger H, Kleiman L. The interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assembly. J Biol Chem 2003, 278:27644-27651.
215. Lys incorporation into human immunodeficiency virus type 1. J Virol 2004, 78:1595-1601.
216. 3 concentration in human immunodeficiency virus type 1 upon its annealing to viral RNA, GagPol incorporation, and viral infectivity. J Virol 2002, 76:9096-9102.
217. 3 aminoacylation and its incorporation into HIV-1. J Biol Chem 2002, 277:17389-17396.
218. Kobbi L, Octobre G, Dias J, Comisso M, Mirande M. Association of mitochondrial lysyl-tRNA synthetase with HIV-1 GagPol involves catalytic domain of the synthetase and transframe and integrase domains of Pol. J Mol Biol 2011, 410:875-886.
219. Jiang M, Mak J, Ladha A, Cohen E, Klein M, Rovinski B, Kleiman L. Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J Virol 1993, 67:3246-3253.
220. Keiler KC, Waller PR, Sauer RT. Role of a peptide tagging system in degradation of proteins synthesized from damaged messenger RNA. Science 1996, 271:990-993.
221. Stewart TS, Roberts RJ, Strominger JL. Novel species of tRNA. Nature 1971, 230:36-38.
222. Roy H, Ibba M. RNA-dependent lipid remodeling by bacterial multiple peptide resistance factors. Proc Natl Acad Sci U S A 2008, 105:4667-4672.
223. Dreher TW. Viral tRNAs and tRNA-like structures. Wiley Interdiscip Rev RNA 2010, 1:402-414.
224. Dreher TW, Tsai CH, Florentz C, Giegé R. Specific valylation of turnip yellow mosaic virus RNA by wheat germ valyl-tRNA synthetase determined by three anticodon loop nucleotides. Biochemistry 1992, 31:9183-9189.
225. Florentz C, Dreher TW, Rudinger J, Giegé R. Specific valylation identity of turnip yellow mosaic virus RNA by yeast valyl-tRNA synthetase is directed by the anticodon in a kinetic rather than affinity-based discrimination. Eur J Biochem 1991, 195:229-234.
226. Felden B, Florentz C, McPherson A, Giegé R. A histidine accepting tRNA-like fold at the 3'-end of satellite tobacco mosaic virus RNA. Nucleic Acids Res 1994, 22:2882-2886.
227. Rietveld K, Linschooten K, Pleij CW, Bosch L. The three-dimensional folding of the tRNA-like structure of tobacco mosaic virus RNA. A new building principle applied twice. EMBO J 1984, 3:2613-2619.
228. Rudinger J, Felden B, Florentz C, Giegé R. Strategy for RNA recognition by yeast histidyl-tRNA synthetase. Bioorg Med Chem 1997, 5:1001-1009.
229. Fechter P, Giegé R, Rudinger-Thirion J. Specific tyrosylation of the bulky tRNA-like structure of brome mosaic virus RNA relies solely on identity nucleotides present in its amino acid-accepting domain. J Mol Biol 2001, 309:387-399.
230. Tyr revealed by protection studies with yeast tyrosyl-tRNA synthetase. Eur J Biochem 1989, 185:331-339.
231. Florentz C, Giegé R. tRNA-like structures in plant viral RNAs. In: Söll D, RajBhandary U, eds. tRNA: Structure, Biosynthesis and Function. Washington, DC: ASM Press; 1995, 141-163.
232. Pleij CW, Rietveld K, Bosch L. A new principle of RNA folding based on pseudoknotting. Nucleic Acids Res 1985, 13:1717-1731.
233. Rietveld K, Pleij CW, Bosch L. Three-dimensional models of the tRNA-like 3' termini of some plant viral RNAs. EMBO J 1983, 2:1079-1085.
234. Florentz C, Giegé R. Contact areas of the turnip yellow mosaic virus tRNA-like structure interacting with yeast valyl-tRNA synthetase. J Mol Biol 1986, 191:117-130.
235. Salazar JC, Ambrogelly A, Crain PF, McCloskey JA, Soll D. A truncated aminoacyl-tRNA synthetase modifies RNA. Proc Natl Acad Sci U S A 2004, 101:7536-7541.
236. Campanacci V, Dubois DY, Becker HD, Kern D, Spinelli S, Valencia C, Pagot F, Salomoni A, Grisel S, Vincentelli R, et al. The Escherichia coli YadB gene product reveals a novel aminoacyl-tRNA synthetase like activity. J Mol Biol 2004, 337:273-283.
237. Sissler M, Delorme C, Bond J, Ehrlich SD, Renault P, Francklyn C. An aminoacyl-tRNA synthetase paralog with a catalytic role in histidine biosynthesis. Proc Natl Acad Sci U S A 1999, 96:8985-8990.
238. Sutherland R, Boon RJ, Griffin KE, Masters PJ, Slocombe B, White AR. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob Agents Chemother 1985, 27:495-498.
239. Hughes J, Mellows G. Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid. Biochem J 1978, 176:305-318.
240. Hughes J, Mellows G. Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase. Biochem J 1980, 191:209-219.
241. Brown MJ, Mensah LM, Doyle ML, Broom NJ, Osbourne N, Forrest AK, Richardson CM, O'Hanlon PJ, Pope AJ. Rational design of femtomolar inhibitors of isoleucyl tRNA synthetase from a binding model for pseudomonic acid-A. Biochemistry 2000, 39:6003-6011.
242. Yanagisawa T, Lee JT, Wu HC, Kawakami M. Relationship of protein structure of isoleucyl-tRNA synthetase with pseudomonic acid resistance of Escherichia coli. A proposed mode of action of pseudomonic acid as an inhibitor of isoleucyl-tRNA synthetase. J Biol Chem 1994, 269:24304-24309.
243. Baker SJ, Zhang YK, Akama T, Lau A, Zhou H, Hernandez V, Mao W, Alley MR, Sanders V, Plattner JJ. Discovery of a new boron-containing antifungal agent, 5-fluoro-1, 3-dihydro-1-hydroxy-2, 1- benzoxaborole (AN2690), for the potential treatment of onychomycosis. J Med Chem 2006, 49:4447-4450.
244. Greenberg Y, King M, Kiosses WB, Ewalt K, Yang X, Schimmel P, Reader JS, Tzima E. The novel fragment of tyrosyl tRNA synthetase, mini-TyrRS, is secreted to induce an angiogenic response in endothelial cells. FASEB J 2008, 22:1597-1605.
245. Wakasugi K, Slike BM, Hood J, Otani A, Ewalt KL, Friedlander M, Cheresh DA, Schimmel P. A human aminoacyl-tRNA synthetase as a regulator of angiogenesis. Proc Natl Acad Sci U S A 2002, 99:173-177.
246. Otani A, Slike BM, Dorrell MI, Hood J, Kinder K, Ewalt KL, Cheresh D, Schimmel P, Friedlander M. A fragment of human TrpRS as a potent antagonist of ocular angiogenesis. Proc Natl Acad Sci U S A 2002, 99:178-183.
247. Zhou Q, Kapoor M, Guo M, Belani R, Xu X, Kiosses WB, Hanan M, Park C, Armour E, Do MH, et al. Orthogonal use of a human tRNA synthetase active site to achieve multifunctionality. Nat Struct Mol Biol 2010, 17:57-61.
248. Dorrell MI, Aguilar E, Scheppke L, Barnett FH, Friedlander M. Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis. Proc Natl Acad Sci U S A 2007, 104:967-972.